Haijun Yu
Impact in
- Oncology top 10%
- Metal complexes synthesis and properties
- Cancer Immunotherapy and Biomarkers
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
Papers in
- Oncology 18
- HER2/EGFR in Cancer Research 3
- Peptidase Inhibition and Analysis 3
-
- Oral health in cancer treatment 4
- Co-authors
- Yunfeng Zhou (15 shared papers)Wei-Qun Ding (2 shared papers)Stuart E. Lind (1 shared paper)Conghua Xie (15 shared papers)Chaoyan Wu (10 shared papers)Fuxiang Zhou (8 shared papers)Yahua Zhong (11 shared papers)Zhi‐Jun Sun (5 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (3 papers)Scientific Reports (3 papers)Cancer Letters (2 papers)PLoS ONE (2 papers)Cancer Cell International (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Haijun Yu
52 papers receiving 805 citations
Peers
Comparison fields: 5 of 98
- Oncology 245
- Otorhinolaryngology 32
- Cancer Research 110
- Clinical Biochemistry 31
- Nutrition and Dietetics 69
Countries citing papers authored by Haijun Yu
This map shows the geographic impact of Haijun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haijun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haijun Yu more than expected).
Fields of papers citing papers by Haijun Yu
This network shows the impact of papers produced by Haijun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haijun Yu. The network helps show where Haijun Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Haijun Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 105 | |
| 2 | 2014 | 55 | |
| 3 | 2017 | 53 | |
| 4 | 2023 | 33 | |
| 5 | 2017 | 31 | |
| 6 | Clioquinol independently targets NF-kappaB and lysosome pathways in human cancer cells. | 2010 | 31 |
| 7 | 2013 | 29 | |
| 8 | 2011 | 28 | |
| 9 | 2017 | 27 | |
| 10 | 2013 | 26 | |
| 11 | 2019 | 26 | |
| 12 | 2013 | 25 | |
| 13 | 2024 | 21 | |
| 14 | 2018 | 19 | |
| 15 | 2023 | 19 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 19 | |
| 18 | 2020 | 18 | |
| 19 | 2014 | 16 | |
| 20 | 2023 | 16 |
About Haijun Yu
Haijun Yu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Physiology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 814 indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (8 papers), Head and Neck Cancer Studies (6 papers), Medical Imaging Techniques and Applications (5 papers), Oral health in cancer treatment (4 papers), Trace Elements in Health (4 papers), MicroRNA in disease regulation (4 papers), HER2/EGFR in Cancer Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (245 citations), Otorhinolaryngology (32 citations), Cancer Research (110 citations), Clinical Biochemistry (31 citations) and Nutrition and Dietetics (69 citations). Haijun Yu has collaborated with scholars based in China, United States and France. Frequent co-authors include Yunfeng Zhou, Wei-Qun Ding, Stuart E. Lind, Conghua Xie, Chaoyan Wu, Fuxiang Zhou, Yahua Zhong, Zhi‐Jun Sun, Ke Yuan and Wei‐Qun Ding. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Scientific Reports, Cancer Letters, PLoS ONE and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.